In Vivo Acquisition of Extended-spectrum Beta-lactamase in Salmonella Enteritidis During Antimicrobial Therapy

Overview

Journal Eur J Clin Microbiol Infect Dis

Publisher Springer

Specialties Infectious Diseases
Microbiology

Date 1995 Aug 1

PMID 8565990

Citations 4

Authors

F Barguellil

C Burucoa

A Amor

J L Fauchere

C Fendri

Affiliations

Soon will be listed here.

Abstract

The recovery of a Salmonella enteritidis strain that acquired resistance to beta-lactams (including cefotaxime), to aminoglycosides and to chloramphenicol subsequent to cefotaxime therapy is reported. This resistance pattern to beta-lactams was due to the presence of an extended-spectrum beta-lactamase. The isoelectric point of this extended-spectrum beta-lactamase was 6.3. The resistance genes were located on a transferable high-molecular-weight plasmid.

Citing Articles

Whole-Genome Sequencing Identifies In Vivo Acquisition of a blaCTX-M-27-Carrying IncFII Transmissible Plasmid as the Cause of Ceftriaxone Treatment Failure for an Invasive Salmonella enterica Serovar Typhimurium Infection.

McCollister B, Kotter C, Frank D, Washburn T, Jobling M Antimicrob Agents Chemother. 2016; 60(12):7224-7235.

PMID: 27671066 PMC: 5119002. DOI: 10.1128/AAC.01649-16.

Extended-spectrum beta-lactamases: a clinical update.

Paterson D, Bonomo R Clin Microbiol Rev. 2005; 18(4):657-86.

PMID: 16223952 PMC: 1265908. DOI: 10.1128/CMR.18.4.657-686.2005.

Molecular epidemiology and characterization of plasmid-encoded beta-lactamases produced by Tunisian clinical isolates of Salmonella enterica serotype Mbandaka resistant to broad-spectrum cephalosporins.

Makanera A, Arlet G, Gautier V, Manai M J Clin Microbiol. 2003; 41(7):2940-5.

PMID: 12843024 PMC: 165341. DOI: 10.1128/JCM.41.7.2940-2945.2003.

Survey and molecular genetics of SHV beta-lactamases in Enterobacteriaceae in Switzerland: two novel enzymes, SHV-11 and SHV-12.

Nuesch-Inderbinen M, Kayser F, Hachler H Antimicrob Agents Chemother. 1997; 41(5):943-9.

PMID: 9145849 PMC: 163830. DOI: 10.1128/AAC.41.5.943.

References

Archambaud M, Gerbaud G, Labau E, Marty N, Courvalin P . Possible in-vivo transfer of beta-lactamase TEM-3 from Klebsiella pneumoniae to Salmonella kedougou. J Antimicrob Chemother. 1991; 27(4):427-36. DOI: 10.1093/jac/27.4.427. View

Ward L, de Sa J, Rowe B . A phage-typing scheme for Salmonella enteritidis. Epidemiol Infect. 1987; 99(2):291-4. PMC: 2249269. DOI: 10.1017/s0950268800067765. View

Mabilat C, Courvalin P . Development of "oligotyping" for characterization and molecular epidemiology of TEM beta-lactamases in members of the family Enterobacteriaceae. Antimicrob Agents Chemother. 1990; 34(11):2210-6. PMC: 172024. DOI: 10.1128/AAC.34.11.2210. View

Sirot D, Sirot J, Labia R, Morand A, Courvalin P, Darfeuille-Michaud A . Transferable resistance to third-generation cephalosporins in clinical isolates of Klebsiella pneumoniae: identification of CTX-1, a novel beta-lactamase. J Antimicrob Chemother. 1987; 20(3):323-34. DOI: 10.1093/jac/20.3.323. View

Ben Redjeb S, Ben Yaghlane H, Boujnah A, Philippon A, Labia R . Synergy between clavulanic acid and newer beta-lactams on nine clinical isolates of Klebsiella pneumoniae, Escherichia coli and Salmonella typhimurium resistant to third-generation cephalosporins. J Antimicrob Chemother. 1988; 21(2):263-6. DOI: 10.1093/jac/21.2.263. View

Hammami A, Arlet G, Ben Redjeb S, Grimont F, Ben Hassen A, Rekik A . Nosocomial outbreak of acute gastroenteritis in a neonatal intensive care unit in Tunisia caused by multiply drug resistant Salmonella wien producing SHV-2 beta-lactamase. Eur J Clin Microbiol Infect Dis. 1991; 10(8):641-6. DOI: 10.1007/BF01975816. View

Schwalbe R, Hoge C, Morris Jr J, OHanlon P, Crawford R, Gilligan P . In vivo selection for transmissible drug resistance in Salmonella typhi during antimicrobial therapy. Antimicrob Agents Chemother. 1990; 34(1):161-3. PMC: 171541. DOI: 10.1128/AAC.34.1.161. View

Legrand P, Fournier G, Bure A, Jarlier V, Nicolas M, Decre D . Detection of extended broad-spectrum beta-lactamases in Enterobacteriaceae in four French hospitals. Eur J Clin Microbiol Infect Dis. 1989; 8(6):527-9. DOI: 10.1007/BF01967473. View

Platt D, Chesham J, Kristinsson K . R-plasmid transfer in vivo: a prospective study. J Med Microbiol. 1986; 21(4):325-30. DOI: 10.1099/00222615-21-4-325. View

10.

Martinez-Suarez J, Martinez J, Lopez De Goicoechea M, Perez-Diaz J, Baquero F, Meseguer M . Acquisition of antibiotic resistance plasmids in vivo by extraintestinal Salmonella spp. J Antimicrob Chemother. 1987; 20(3):452-3. DOI: 10.1093/jac/20.3.452. View

11.

Ben Hassen A, Bejaoui M, Lakhoua M, Ben Redjeb S . [Epidemiological pattern of the resistance of 153 Salmonella strains (S. typhi excluded) isolated in a Tunisian pediatric unit from 1985 to 1990]. Pathol Biol (Paris). 1993; 41(8):706-12. View

12.

Poupart M, Chanal C, Sirot D, Labia R, Sirot J . Identification of CTX-2, a novel cefotaximase from a Salmonella mbandaka isolate. Antimicrob Agents Chemother. 1991; 35(7):1498-500. PMC: 245200. DOI: 10.1128/AAC.35.7.1498. View

13.

Platt D, Sommerville J, Gribben J . Sequential acquisition of R-plasmids in vivo by Salmonella typhimurium. J Antimicrob Chemother. 1984; 13(1):65-9. DOI: 10.1093/jac/13.1.65. View

14.

Datta N, Richards H, Datta C . Salmonella typhi in vivo acquires resistance to both chloramphenicol and co-trimoxazole. Lancet. 1981; 1(8231):1181-3. DOI: 10.1016/s0140-6736(81)92350-3. View

15.

Naumovski L, Quinn J, Miyashiro D, Patel M, Bush K, Singer S . Outbreak of ceftazidime resistance due to a novel extended-spectrum beta-lactamase in isolates from cancer patients. Antimicrob Agents Chemother. 1992; 36(9):1991-6. PMC: 192997. DOI: 10.1128/AAC.36.9.1991. View

16.

Petit A, Gerbaud G, Sirot D, Courvalin P, Sirot J . Molecular epidemiology of TEM-3 (CTX-1) beta-lactamase. Antimicrob Agents Chemother. 1990; 34(2):219-24. PMC: 171560. DOI: 10.1128/AAC.34.2.219. View